Furthermore, concentrations of all tested parameters were significantly higher in patients with stage III and IV BC in comparison to benign breast tumour subjects (p < 0.001), in whom, however, the concentration of MMP-7 was higher than in healthy participants (p = 0.03). This evidence concerns the gene MMP7 and breast benign neoplasm.